IVRN (Innoveren Scientific) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 27, 2026)


IVRN Innoveren Scientific Inc IVRN
16 GF Score
Price $0.00
View Full Analysis

What is Innoveren Scientific Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Innoveren Scientific's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.


IVRN vs GNCA, ISCO, FNAM: Margin of Safety % (DCF Earnings Based) Comparison

For the Biotechnology subindustry, Innoveren Scientific's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Innoveren Scientific Margin of Safety % (DCF Earnings Based) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Innoveren Scientific's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Innoveren Scientific's Margin of Safety % (DCF Earnings Based) falls into.


IVRN
16GF Score
Innoveren Scientific Inc IVRN
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Innoveren Scientific Business Description

Address 2202 N West Shore Boulevard, Suite 200, Tampa, FL, USA, 33607
Innoveren Scientific Inc Formerly H-CYTE Inc is a hybrid biopharmaceutical company dedicated to developing and delivering new treatments for patients with chronic respiratory and pulmonary disorders. It has two divisions: the Healthcare Medical Biosciences Division (which includes the Infusion Vertical and the Biologics Vertical) and the DenerveX medical device division.
16GF Score

Get the complete analysis for IVRN

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price